Julia Bonavitacola

A meta-analysis evaluated the efficacy of various monoclonal antibodies in treating patients with myasthenia gravis (MG).

Mobile health models that include artificial intelligence and smartphone imaging can help address gaps in early detection.

Changes in PrEP for HIV expand choice and reduce risk as new research continues to look for an elusive cure.

Patients with narcolepsy type 1 reported high disease burden, including chronic symptoms like hallucinations, sleep paralysis, and difficulty concentrating.

Late-breaking abstracts presented during the Sleep 2026 Annual Meeting provided new data on how the time of year could change sleep duration and the efficacy of low-sodium oxybate.

The American Heart Association’s Life’s Essential 8 indicates that the key to a healthy heart is through the treatment of sleep, including in obstructive sleep apnea (OSA) and narcolepsy.

The use of artificial intelligence (AI) in sleep medicine could cause pitfalls on the practical and training ends, affecting patient care.

A session held during the Sleep 2026 Annual Conference focused on how wearables played a role in obstructive sleep apnea.

Abstracts presented during the Sleep 2026 Annual Meeting focused on the potential benefits of using oveporexton in narcolepsy type 1.

The conference, set to take place in Baltimore, Maryland, will feature 4 days of sessions focusing on sleep medicine and how it affects overall health.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The use of in-hospital statins in older adults admitted to an acute geriatric ward was associated with in-hospital mortality.

The treatment worked in patients with generalized myasthenia gravis (gMG) regardless of previous immunosuppressive treatment or concomitant use of other gMG treatments.

Despite increases in influenza vaccine rates before the pandemic in the Bronx, rates have decreased between 2020 and 2023.

A total of 2288 cases of measles were confirmed in the US for the full year of 2025, suggesting that the cases are set to double in 2026.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The fluocinolone acetonide intravitreal implant showed durable improvements in anatomical and functional outcomes over a follow-up period of 36 months.

Most patients achieved stable or reduced lesion burden and the treatment was well tolerated by patients.

James F. Howard, MD, discusses what he believes will be the next steps in treating myasthenia gravis.

Asthma and Allergy Awareness Month shines light on the ways that asthma can affect long-term health.

Older adults began to experience self-reported visual disability at a threshold of 1.60 logCS, which provides a benchmark for contrast sensitivity.

Men with multiple sclerosis (MS) were more likely to lose income earlier in life compared with women with MS.

Mental Health Awareness Month puts a spotlight on the prevalence of mental illness throughout the country, as well as reduces the stigma surrounding it.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A survey of health care and life sciences executives found that the top challenges in the sectors included policy uncertainty and declining reimbursement rates.

Despite high US health care spending, data show lower life expectancy, worse maternal mortality, and too few primary care doctors.

The American Thoracic Society 2026 International Conference included sessions that focused on topics such as pulmonary rehabilitation and global disparities in thoracic care.

James F. Howard, MD, discusses the significance of the FDA expanding the label for efgartigimod in patients with generalized myasthenia gravis (gMG).

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

New data examine switching biologics in severe asthma and inhaled treprostinil's effect on lung function in idiopathic pulmonary fibrosis (IPF).